Risk factor
Meaningful price volatility
Profitability factor
Greatly overvalued vs peers
About
Operating from Zhengzhou, China, Henan Taloph Pharmaceutical Stock Co., Ltd. specializes in the research, development, production, and sale of a wide array of Chinese and Western medicines across the nation. The company's product line encompasses various forms, such as oral liquids, tablets, capsules, and injectable fluids. Notable products include Huperzine A tablets, phenoxybenzamine hydrochloride tablets, and pazufloxacin mesylate sodium chloride injections, alongside a selection of other infusion products. Taloph Pharmaceutical serves a diverse client base, including hospitals, pharmacies, and direct consumers. It was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITD.